BioHealth News Archive

Head of JLABS @ Washington, D.C., Sally Allain, MSc., MBA, Guests on BioTalk

Head of JLABS @ Washington, D.C., Sally Allain, MSc., MBA, Guests on BioTalk

Sally Allain, MSc., MBA, Head of JLABS @ Washington, D.C. joins Rich Bendis on BioTalk to discuss her career, the decision to open a…

Read More
J&J, BARDA pick 7 startups to back in fight against COVID-19—and beyond | FierceBiotech

J&J, BARDA pick 7 startups to back in fight against COVID-19—and beyond | FierceBiotech

As the world scrambles to develop diagnostics, treatments and vaccines for COVID-19, one big question looms: How will we face the next pandemic? Johnson…

Read More
GSK is hiring in Richmond.

GSK is hiring in Richmond.

Microbiology Team Leader - https://jobs.gsk.com/en-gb/jobs/241125?lang=it-it (we also have a video of the line manager talking about the role, if you can add it to the newsletter) New Product…

Read More
Vaccitech Awarded U.K. Grant for COVID Vaccine Research

Vaccitech Awarded U.K. Grant for COVID Vaccine Research

Vaccitech officials say the company received a U.K. government grant to support research with its next-generation technology platform to protect against COVID-19. The grant…

Read More
Alexandria Venture Investments Recognized as #1 Most Active Biopharma Investor for Third Consecutive Year

Alexandria Venture Investments Recognized as #1 Most Active Biopharma Investor for Third Consecutive Year

PASADENA, Calif., Sept. 4, 2020 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban…

Read More
Sanofi, GSK start human trial of their COVID-19 vaccine

Sanofi, GSK start human trial of their COVID-19 vaccine

Pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) on Thursday started a clinical trial for their jointly developed COVID-19 vaccine candidate. A total of…

Read More
Skincare of the Future QuickFire Challenge – Challenge | JLABS

Skincare of the Future QuickFire Challenge – Challenge | JLABS

Advances in science and technology can drive the next generation of skincare innovations.  Today, cutting edge dermatological research and technologies hold the potential to revolutionize pore minimizing and anti-aging solutions.  To that end, Johnson &…

Read More
Nobelpharma Press Release — MCEDC

Nobelpharma Press Release — MCEDC

ROCKVILLE, Md. — Recognizing the benefits of proximity to leading U.S. researchers, regulators and advocacy groups, Nobelpharma America, LLC has chosen Montgomery County, Maryland…

Read More
TruGenomix, a Veteran-Led Biotech Instrumental in Early Identification & Awareness of PTSD, Raises $1.8 Million Seed Round, Led by Sanford Health & Viking Global

TruGenomix, a Veteran-Led Biotech Instrumental in Early Identification & Awareness of PTSD, Raises $1.8 Million Seed Round, Led by Sanford Health & Viking Global

TruGenomix recently announced $1.8 million in financing in a seed round led by Sanford Health. The startup, a graduate of the Illumina Accelerator program…

Read More

Biotech leaders call for Covid-19 data transparency, FDA independence

WASHINGTON — A group of prominent biotech CEOs are calling on their peers and the federal government to hold themselves to the highest standards…

Read More
Ceres Nanosciences Receives $6.5M NIH Award

Ceres Nanosciences Receives $6.5M NIH Award

MANASSAS, Va. — September 2, 2020 — Ceres Nanosciences, a privately held company that makes innovative products to improve diagnostic testing, announced it has been…

Read More
NIH Awards MicroGEM up to $40.9M to Fast-Track Rapid, No-Lab COVID-19 Saliva Test

NIH Awards MicroGEM up to $40.9M to Fast-Track Rapid, No-Lab COVID-19 Saliva Test

CHARLOTTESVILLE, Va., Sept. 2, 2020 /PRNewswire/ -- MicroGEM today announced it has been awarded up to $40.9 million by the National Institutes of Health (NIH),…

Read More
AstraZeneca Launches 30,000-Patient Phase III U.S. Trial of COVID-19 Vaccine

AstraZeneca Launches 30,000-Patient Phase III U.S. Trial of COVID-19 Vaccine

AstraZeneca said today it has launched a 30,000-patient Phase III trial in the U.S. of AZD1222, the COVID-19 vaccine it is co-developing with the…

Read More
California developer Alexandria Real Estate proposes office, lab building at Baltimore’s Port Covington – Baltimore Business Journal

California developer Alexandria Real Estate proposes office, lab building at Baltimore’s Port Covington – Baltimore Business Journal

The 170,000-square-foot building would be located near Rye Street Tavern.   {iframe}https://www.bizjournals.com/baltimore/news/2020/09/01/alexandria-proposes-port-covington-building.html{/iframe}

Read More
Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration – News | JLABS

Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration – News | JLABS

WASHINGTON, D.C., August 27, 2020 - Johnson & Johnson Innovation LLC today announced the first companies to be part of its medical countermeasure innovation…

Read More